| Quarterly Financials | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
Revenue  | 270 | 285 | 278 | 275 | 276 | 691 | 835 | 831 | 1,026 | 1,050 | 1,023 | 964 | 1,098 | 1,163 | 1,186 | 1,255 | 1,326 | 1,409 | 1,381 | 1,468 | 1,578 | 1,748 | 1,902 | 1,957 | 2,064 | 2,168 | 2,113 |
| Expenses | 239 | 253 | 245 | 228 | 514 | 564 | 636 | 634 | 756 | 787 | 729 | 729 | 802 | 818 | 828 | 874 | 948 | 976 | 949 | 1,041 | 1,156 | 1,257 | 1,443 | 1,398 | 1,505 | 1,560 | 1,577 |
| EBITDA | 31 | 31 | 32 | 47 | -239 | 127 | 200 | 197 | 270 | 262 | 293 | 235 | 296 | 345 | 359 | 381 | 379 | 433 | 432 | 427 | 422 | 491 | 459 | 559 | 559 | 608 | 536 |
| Operating Profit % | 9 % | 10 % | 8 % | 8 % | -101 % | 13 % | 20 % | 21 % | 24 % | 23 % | 25 % | 22 % | 25 % | 28 % | 28 % | 28 % | 26 % | 28 % | 29 % | 27 % | 25 % | 26 % | 23 % | 27 % | 26 % | 27 % | 24 % |
| Depreciation | 12 | 11 | 11 | 12 | 26 | 52 | 48 | 48 | 54 | 54 | 55 | 58 | 57 | 58 | 57 | 60 | 56 | 58 | 61 | 70 | 77 | 84 | 98 | 101 | 104 | 108 | 111 |
| Interest | 10 | 21 | 27 | 25 | 35 | 53 | 46 | 45 | 27 | 27 | 25 | 22 | 22 | 22 | 20 | 20 | 19 | 9 | 11 | 21 | 24 | 34 | 52 | 55 | 55 | 54 | 60 |
| Profit Before Tax | 9 | -0 | -6 | 10 | -300 | 22 | 105 | 105 | 190 | 182 | 213 | 154 | 216 | 265 | 281 | 301 | 304 | 366 | 360 | 336 | 321 | 374 | 309 | 403 | 400 | 446 | 365 |
| Tax | -0 | 1 | -4 | -43 | 14 | 6 | 15 | 35 | 43 | 37 | 23 | 31 | 44 | -192 | 59 | 50 | 63 | 90 | 70 | 84 | 85 | 92 | 70 | 84 | 93 | -45 | 64 |
| Net Profit | 9 | -1 | -2 | 53 | -314 | 17 | 90 | 70 | 147 | 145 | 190 | 124 | 173 | 457 | 222 | 251 | 240 | 277 | 289 | 252 | 236 | 282 | 239 | 319 | 308 | 491 | 301 |
| EPS in ₹ | 0.17 | -0.03 | -0.03 | 0.91 | -4.34 | 0.18 | 1.00 | 0.76 | 1.52 | 1.50 | 1.96 | 1.28 | 1.78 | 4.72 | 2.29 | 2.58 | 2.47 | 2.85 | 2.98 | 2.59 | 2.43 | 2.90 | 2.46 | 3.28 | 3.17 | 5.05 | 3.10 |
Max Healthcare Institute
Max Healthcare Institute
1,086.25
+10.10
(0.94%)
Market Cap
1,05,667.07 Cr
PE Ratio
73.80
Volume
6,80,966.00
Day High - Low
1,087.90 - 1,071.65
52W High-Low
1,314.30 - 933.80
Key Fundamentals
Market Cap
1,05,667.07 Cr
EPS
11.07
PE Ratio
73.80
PB Ratio
10.42
Book Value
87.31
EBITDA
2,004.40
Dividend Yield
0.14 %
Industry
Healthcare Services Sector
Hospitals Return on Equity
11.47
Debt to Equity
0.24
Analyst Rating and Forecast
- By Refinitiv from22 analysts
Actual
Company News
View All News
Max Healthcare Institute Limited will participate in Nuvama India Conference 2026 on February 9 and 17th Kotak Chasing Growth Conference 2026 on February 23, 2026 under Regulation 30.
Max Healthcare management confirms agreements with insurance companies for annual price revisions during recent conference call, indicating structured pricing mechanisms for healthcare services.
Max Healthcare Q3 Net Profit Rises 25% to ₹3B
Feb 05, 2026
Feb 05, 2026Max Healthcare Institute reported Q3 consolidated net profit of ₹3.00 billion, up from ₹2.40 billion year-on-year, though falling short of analyst estimates of ₹3.90 billion.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
7,647.50 | #1 1,09,959.32 | 58.54 | #1 21,994.30 | 14.76 | #1 1,505 | 36.08 | 74.02 | |
1,086.25 | #2 1,05,667.07 | #6 73.80 | #3 7,184.10 | #1 28.65 | #2 1,076 | #3 26.01 | 63.79 | |
914.95 | 69,074.90 | 69.80 | 7,849.70 | 13.25 | 809 | -22.38 | 59.63 | |
1,844.10 | 37,686.18 | 47.96 | 5,575.00 | 12.29 | 790 | -34.33 | 54.09 | |
629.20 | 32,600.18 | 90.35 | 4,286.70 | 15.12 | 337 | -8.85 | 65.73 | |
1,173.10 | 31,531.80 | 61.37 | 3,771.40 | 12.59 | 481 | -33.52 | 57.90 | |
700.45 | 28,027.73 | 90.21 | 3,067.00 | 21.98 | 415 | -43.89 | 65.81 | |
452.60 | 14,323.43 | 89.27 | 1,757.00 | 27.64 | 110 | #1 54.61 | 42.67 | |
1,209.70 | 12,285.61 | #1 47.67 | 1,566.90 | 17.46 | 244 | 7.26 | 51.36 | |
596.95 | 8,417.45 | 319.59 | 2,257.70 | 17.03 | 49 | -201.28 | 46.53 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
28.65 %
Net Income Growth
1.73 %
Cash Flow Change
30.09 %
ROE
-8.82 %
ROCE
-11.54 %
EBITDA Margin (Avg.)
-6.72 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 1,453 | 2,217 | 3,160 | 3,314 | 3,366 | 3,974 | 8,544 | 9,189 | 10,102 | 12,000 | 15,215 |
| Fixed Assets | 740 | 1,478 | 2,244 | 2,227 | 2,192 | 851 | 6,536 | 7,018 | 7,039 | 8,784 | 11,502 |
| Current Assets | 383 | 289 | 349 | 454 | 447 | 2,915 | 1,125 | 1,000 | 1,943 | 1,706 | 1,593 |
| Capital Work in Progress | 18 | 12 | 46 | 38 | 87 | 28 | 27 | 151 | 252 | 553 | 901 |
| Investments | 143 | 0 | 0 | 0 | 1 | 2,182 | 1 | 1 | 1 | 2 | 3 |
| Other Assets | 552 | 728 | 870 | 1,049 | 1,086 | 913 | 1,981 | 2,020 | 2,810 | 2,661 | 2,809 |
| Total Liabilities | 1,453 | 2,217 | 3,160 | 3,314 | 3,366 | 3,974 | 8,544 | 9,189 | 10,102 | 12,000 | 15,215 |
| Current Liabilities | 282 | 419 | 381 | 477 | 1,140 | 1,010 | 777 | 757 | 1,046 | 1,249 | 1,814 |
| Non Current Liabilities | 339 | 672 | 1,660 | 1,806 | 1,262 | 411 | 2,129 | 2,149 | 1,647 | 2,343 | 4,020 |
| Total Equity | 832 | 1,127 | 1,119 | 1,031 | 963 | 2,553 | 5,639 | 6,283 | 7,410 | 8,408 | 9,381 |
| Reserve & Surplus | 343 | 587 | 655 | 627 | 426 | 2,016 | 4,673 | 5,313 | 6,439 | 7,436 | 8,409 |
| Share Capital | 489 | 533 | 537 | 537 | 537 | 537 | 966 | 970 | 971 | 972 | 972 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 16 | -40 | 4 | -6 | -2 | -211 | 516 | -318 | 893 | -395 | -319 |
| Investing Activities | -194 | -364 | -104 | -124 | -17 | -2,641 | 206 | -772 | -102 | -1,253 | -1,614 |
| Operating Activities | 64 | 53 | 156 | 166 | 89 | 77 | 118 | 749 | 1,284 | 1,122 | 1,459 |
| Financing Activities | 145 | 271 | -48 | -48 | -74 | 2,353 | 191 | -294 | -289 | -264 | -164 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
| Promoter | 70.46 % | 70.46 % | 60.91 % | 60.68 % | 50.64 % | 50.64 % | 23.80 % | 23.78 % | 23.77 % | 23.76 % | 23.76 % | 23.75 % | 23.75 % | 23.74 % | 23.74 % | 23.74 % | 23.74 % | 23.74 % | 23.74 % | 23.72 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.01 % | 0.00 % | 0.01 % | 0.01 % | 57.33 % | 56.98 % | 57.29 % | 56.93 % | 54.74 % | 54.76 % | 51.80 % | 50.55 % |
| DIIs | 4.86 % | 7.93 % | 8.70 % | 15.60 % | 17.49 % | 19.26 % | 21.00 % | 20.47 % | 19.35 % | 11.90 % | 11.32 % | 11.34 % | 14.96 % | 15.36 % | 15.14 % | 15.55 % | 17.58 % | 17.42 % | 20.03 % | 21.20 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 5.18 % | 5.76 % | 5.20 % | 5.23 % | 5.41 % | 4.94 % | 4.54 % | 4.36 % | 3.72 % | 3.54 % | 3.55 % | 3.34 % | 3.29 % | 3.24 % | 3.18 % | 3.13 % | 3.31 % | 3.42 % | 3.08 % | 3.13 % |
| Others | 19.50 % | 15.84 % | 25.18 % | 18.49 % | 26.46 % | 25.16 % | 50.65 % | 51.38 % | 53.15 % | 60.80 % | 61.36 % | 61.56 % | 0.67 % | 0.67 % | 0.65 % | 0.64 % | 0.63 % | 0.66 % | 1.35 % | 1.38 % |
| No of Share Holders | 45,339 | 70,655 | 91,937 | 1,11,877 | 1,20,079 | 1,05,000 | 1,01,659 | 1,11,701 | 1,04,656 | 1,11,374 | 1,18,635 | 1,11,338 | 1,27,009 | 1,36,254 | 1,37,856 | 1,40,028 | 1,51,633 | 1,62,119 | 1,80,891 | 2,03,837 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 1.5 | 1.5 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.14 | 0.14 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 08 Sept 2023 |  Dividend | ₹ 1.00 /share | 08 Sept 2023 | 519.90 | 602.65 |
| 27 Sept 2023 |  Annual General Meeting | NA | 27 Sept 2023 | 553.60 | 566.10 |
| 23 Aug 2024 | Dividend | ₹ 1.50 /share | 23 Aug 2024 | 835.15 | 869.30 |
| 20 Sept 2024 | Annual General Meeting | NA | 20 Sept 2024 | 882.75 | 984.55 |
| 05 Nov 2024 |  Quarterly Result Announcement | NA | 05 Nov 2024 | 994.50 | 1,036.60 |
| 30 Jan 2025 | Quarterly Result Announcement | NA | 30 Jan 2025 | 1,082.95 | 1,025.90 |
| 20 May 2025 | Quarterly Result Announcement | NA | 20 May 2025 | 1,159.90 | 1,187.10 |
| 04 Jul 2025 | Dividend | ₹ 1.50 /share | 04 Jul 2025 | 1,187.10 | 1,301.40 |
| 30 Jul 2025 | Annual General Meeting | NA | 30 Jul 2025 | 1,190.20 | 1,274.30 |
| 13 Aug 2025 | Quarterly Result Announcement | NA | 13 Aug 2025 | 1,272.30 | 1,260.60 |
| 14 Nov 2025 | Quarterly Result Announcement | NA | 14 Nov 2025 | 1,135.30 | 1,098.00 |
| 05 Feb 2026 | Quarterly Result Announcement | NA | 05 Feb 2026 | 975.50 | 1,026.30 |
Announcements
Announcement under Regulation 30 (LODR)-Earnings Call Transcript6 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Investor PresentationFeb 07, 2026
Feb 07, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 06, 2026
Feb 06, 2026Audio Recording Of Earnings Call Held On February 6 2026Feb 06, 2026
Feb 06, 2026Presentation On Earnings UpdateFeb 05, 2026
Feb 05, 2026Board Meeting Outcome for Meeting Held On February 5 2026Feb 05, 2026
Feb 05, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 05, 2026
Feb 05, 2026Results - Financial Results For The Quarter And Nine Months Ended December 31 2025Feb 05, 2026
Feb 05, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 04, 2026
Feb 04, 2026Grant Of Options Under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022Feb 04, 2026
Feb 04, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 29, 2026
Jan 29, 2026Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 29, 2026
Jan 29, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 28, 2026
Jan 28, 2026Board Meeting Intimation for Consideration And Approval Of Financial ResultsJan 28, 2026
Jan 28, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Jan 06, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJan 02, 2026
Jan 02, 2026Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 30, 2025
Dec 30, 2025Closure of Trading WindowDec 29, 2025
Dec 29, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 19, 2025
Dec 19, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 18, 2025
Dec 18, 2025Announcement under Regulation 30 (LODR)-AcquisitionDec 18, 2025
Dec 18, 2025Outcome Of Board MeetingDec 18, 2025
Dec 18, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 09, 2025
Dec 09, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSDec 03, 2025
Dec 03, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 21, 2025
Nov 21, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 19, 2025
Nov 19, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 17, 2025
Nov 17, 2025Audio Recording Of Earnings Call Held On November 17 2025Nov 17, 2025
Nov 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 16, 2025
Nov 16, 2025Presentation On Earnings UpdateNov 14, 2025
Nov 14, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 14, 2025
Nov 14, 2025Board Meeting Outcome for Meeting Held On November 14 2025Nov 14, 2025
Nov 14, 2025Results - Financial Results For The Quarter And Half Year Ended September 30 2025Nov 14, 2025
Nov 14, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 14, 2025
Nov 14, 2025Grant Of Options Under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022Nov 14, 2025
Nov 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 13, 2025
Nov 13, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 10, 2025
Nov 10, 2025Board Meeting Intimation for Consideration And Approval Of Financial ResultsNov 08, 2025
Nov 08, 2025Approval Of Scheme Of Amalgamation Between Crosslay Remedies Limited And Jaypee Healthcare LimitedNov 07, 2025
Nov 07, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 07, 2025
Nov 07, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 22, 2025
Oct 22, 2025Communication To Members - 100 Days Campaign - Saksham NiveshakOct 09, 2025
Oct 09, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 07, 2025
Oct 07, 2025Announcement under Regulation 30 (LODR)-Credit RatingOct 02, 2025
Oct 02, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Oct 01, 2025
Oct 01, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 29, 2025
Sep 29, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 22, 2025
Sep 22, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 04, 2025
Sep 04, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 29, 2025
Aug 29, 2025Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 61.79
ATR(14)
Volatile 29.00
STOCH(9,6)
Overbought 87.88
STOCH RSI(14)
Overbought 97.45
MACD(12,26)
Bullish 11.59
ADX(14)
Strong Trend 29.23
UO(9)
Bearish 69.31
ROC(12)
Uptrend And Accelerating 12.44
WillR(14)
Overbought -0.91
About Max Healthcare Institute
Max Healthcare Institute Limited is an Indian integrated healthcare provider operating a network of healthcare facilities, primarily in North India. The company offers a range of medical services including primary, secondary, tertiary, and quaternary care across various specialties. It operates 17 healthcare facilities in Delhi NCR, Haryana, Punjab, Uttarakhand, and...more
Website
Chairperson NameAbhay Soi
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
